Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CAI
CAI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CAI News
Caris Life Sciences Approves $100M Share Repurchase Program
Jun 08 2026
seekingalpha
Caris Life Sciences Authorized to Repurchase $100 Million in Stock
Jun 08 2026
NASDAQ.COM
Caris Life Sciences Announces $100 Million Share Repurchase Program
Jun 08 2026
PRnewswire
AI Technology Corrects Cancer Diagnosis, Saves Lives
May 26 2026
PRnewswire
Caris Lookback Program Identifies 13,293 Eligible Patients for New Therapies
May 15 2026
PRnewswire
Caris Lookback Program Identifies 13,293 Eligible Patients for New Therapies
May 15 2026
Newsfilter
MindBio Leverages AI Voice Analysis for Impairment Detection
May 13 2026
Globenewswire
MindBio Leverages AI Voice Analysis for Impairment Detection
May 13 2026
Newsfilter
Caris Study Reveals Gene Panels Miscalculate Tumor Mutational Burden
May 11 2026
PRnewswire
Caris Study Reveals New Standard for TMB Measurement
May 11 2026
Newsfilter
Caris Life Sciences Q1 2026 Earnings Call Highlights
May 08 2026
seekingalpha
Caris (CAI) Q1 2026 Earnings Call Transcript
May 07 2026
NASDAQ.COM
Caris Launches AI-Driven Breast Cancer Recurrence Risk Assessment Test
May 05 2026
PRnewswire
Caris ChromoSeq Receives MolDX Approval for Myeloid Malignancies
May 04 2026
PRnewswire
Caris ChromoSeq Receives MolDX Approval for Myeloid Malignancies
May 04 2026
Newsfilter
Caris Develops Predictive Model for Glioblastoma Therapy Selection
Apr 29 2026
NASDAQ.COM
Show More News
